Preclinical evaluation of a cross-protective ß-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Joseph Torresi, William R. Heath, Julio Montoya et al.|Research Square|2024Cited by 2
Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59Linda Earnest, Joseph Torresi, Daniel Fernandez‐Ruiz et al.|SSRN Electronic Journal|2024Cited by 0